Why Novo Nordisk (NVO) Is Plummeting Today
Specifically, the weight of patients who received Novo's anti-obesity drug, CagriSema, declined by an average of 20.4% in 68 weeks, versus the 25% average weight loss that Novo had expected the treatment...
Novo Nordisk A S (NVO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 13,305,474 | $1,584,282,877 | -1% | 0.64% |
| 2. | Renaissance Technologies Jim Simons | 8,189,315 | $975,101,737 | -11% | 1.46% |
| 3. | GQG Partners Rajiv Jain | 7,438,073 | $885,651,419 | +77% | 1.38% |
| 4. | Markel Gayner Asset Management Tom Gayner | 2,150,000 | $256,000,501 | 2.3% | |
| 5. | 1,342,800 | $159,887,196 | -25% | 0.03% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,527,772 | $2,330,498,036 | 1.73% | |
| 2. | 12,975,409 | $1,342,306,092 | 0.13% | |
| 3. | 12,663,225 | $1,310,010,512 | 0.1% | |
| 4. | 10,614,811 | $1,098,102,521 | 0.09% | |
| 5. | 8,631,264 | $892,904,261 | 18.17% |
News See All
Novo Nordisk A/S (NVO) Fell as its Weight Loss Drug Faced Supply Constraints
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” third quarter 2024, investor letter. A copy of the letter can be downloaded here.
Novo Nordisk (NVO) To Diversify Revenue Streams With $1.2bn Investment In Denmark
Novo Nordisk (NVO) is making headlines with its inventive investment of $1.2 billion aimed at building a new production facility in Odense, Denmark.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Here’s Why Novo Nordisk A/S (NVO) Fell in Q3
PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be downloaded here. Given concerns regarding the decreasing pace of U.S.
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.
12 Most Profitable Pharmaceutical Stocks Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
12 Best ADR Stocks To Invest In According to Analysts
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank, representing shares of a foreign company. ADRs enable U.S.
Louis Navellier's Top 10 Stock Picks Heading into 2025
Louis Navellier, Chairman and Founder of Navellier & Associates, is a renowned American investor who is celebrated for his skill in navigating the stock market and delivering impressive profits.
10 Most Profitable European Stocks To Invest In
After the U.S. Presidential elections, the global economies might face trade tariff tribulation as the Trump administration is expected to accelerate the trade war.
Billionaire Hedge Funds
